The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Versant Venture Capital V (canada), Lp since 2018.
The trader's CIK number is 1612235.
At the time of the last reporting, Versant Venture Capital V (canada), Lp was the 10% Owner of Crispr Therapeutics Ag. (stock ticker symbol CRSP).
Also see all insider trading activities at Crispr Therapeutics Ag.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | CRSP | 0 | $0 | 124,835 | $6,346,961 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-04-24 | CRSP | Sale | 22,841 | 50.90 | 1,162,606 |
| 2018-04-23 | CRSP | Sale | 101,994 | 50.83 | 5,184,355 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Versant Venture Capital V (canada), Lp (10% Owner of Crispr Therapeutics Ag at the time of this reporting) see the Securities and Exchange Commission (SEC) website.